Skip to main navigation Skip to search Skip to main content

Somavaratan, a Long-Acting Recombinant Human Growth Hormone (rhGH), for the Treatment of Adults with Growth Hormone Deficiency (AGHD): Results of VITAL, an Open-Label, Dose-Finding, International, Phase 2 Study (NCT02526420)

  • Beverly M.K. Biller
  • , Daniela Rogoff
  • , Trish Rice
  • , Shelby A Young
  • , R. William Charlton
  • , Bert Bakker
  • , Maria Koltowska-Häggström
  • , Eric Humphriss
  • , Timothy S Bailey
  • , Kimvir Singh Dhillon
  • , Ken Ho
  • , Laurence Katznelson
  • , Kylie McLachlan
  • , Shlomo Melmed
  • , Samer Nakhle
  • , Duncan J Topliss
  • , Whitney W. Woodmansee
  • , Kevin C.J. Yuen
  • , Martin Bidlingmaier
  • , Christian J Strasburger
  • Harvard University
  • Versartis, Inc.
  • Premier Research
  • Pfizer
  • AMCR Institute Inc.
  • Therapeutic Research Institute of Orange County
  • Princess Alexandra Hospital
  • Stanford University
  • Cedars-Sinai Medical Center
  • Palm Medical Research
  • Alfred Health
  • Mayo Clinic
  • Swedish Neuroscience Institute
  • Klinikum der Universität München
  • Charité

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
Journal99th Annual Meeting of the Endocrine Society
StatePublished - Apr 1 2017
Externally publishedYes

Disciplines

  • Endocrinology
  • Medicine and Health Sciences
  • Internal Medicine

Cite this